Concepedia

Haijun Gu

HG

Statistics

Publications

4

Citations

101

H-Index

4

Active since

2020

Affiliations

East China Normal University(Current)

Haijun Gu is an author at East China Normal University specializing in pharmacology, molecular oncology, and structure-activity relationships.

ORCID

Publications per year

2020–2023

4

Publications

4

Synthesis and Biological Evaluation of B-Cell Lymphoma 6 Inhibitors of <i>N</i>-Phenyl-4-pyrimidinamine Derivatives Bearing Potent Activities against Tumor Growth

Weikai Guo, Yajing Xing, Qiansen Zhang et al. · Journal of Medicinal Chemistry · 2020 · 33 citations · Full text

, , +14

A potent and selective small molecule inhibitor of myoferlin attenuates colorectal cancer progression

Yuan He, Weiqiong Kan, Yunqi Li et al. · Clinical and Translational Medicine · 2021 · 28 citations · Full text

, , +16

Discovery of a Novel Potent STAT3 Inhibitor HP590 with Dual p-Tyr<sup>705</sup>/Ser<sup>727</sup> Inhibitory Activity for Gastric Cancer Treatment

Peng He, Ying Miao, Yue Sun et al. · Journal of Medicinal Chemistry · 2022 · 26 citations · Full text

, , +8

Discovery of a Highly Potent and Selective MYOF Inhibitor with Improved Water Solubility for the Treatment of Gastric Cancer

Haijun Gu, Ting Zhang, Tian Guan et al. · Journal of Medicinal Chemistry · 2023 · 14 citations · Full text

, , +15

1–4 of 4